These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 11954875
1. Treatment of acute cluster headache with 20 mg sumatriptan nasal spray--an open pilot study. Schuh-Hofer S, Reuter U, Kinze S, Einhäupl KM, Arnold G. J Neurol; 2002 Jan; 249(1):94-9. PubMed ID: 11954875 [Abstract] [Full Text] [Related]
3. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. CNS Drugs; 2005 Jan; 19(2):125-36. PubMed ID: 15697326 [Abstract] [Full Text] [Related]
4. [Sumatriptan nasal spray for the treatment of cluster headache]. Watanabe M, Oda A. No To Shinkei; 2005 Jan; 57(1):65-8. PubMed ID: 15782603 [Abstract] [Full Text] [Related]
13. [Therapeutic Effects of Intranasal Sumatriptan for Cluster Headache]. Ishii M, Katoh H, Imawaka M, Kasai H, Ishibashi M. Yakugaku Zasshi; 2019 Aug 28; 139(1):107-111. PubMed ID: 30606916 [Abstract] [Full Text] [Related]
14. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM. Headache; 2018 May 28; 58(5):676-687. PubMed ID: 29878341 [Abstract] [Full Text] [Related]
15. Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study. Carpay JA, Linssen WH, Koehler PJ, Arends LR, Tiedink HG. Headache; 2003 Apr 28; 43(4):395-9. PubMed ID: 12656711 [Abstract] [Full Text] [Related]
16. Nasal sumatriptan is effective in treatment of migraine attacks in children: A randomized trial. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Neurology; 2004 Mar 23; 62(6):883-7. PubMed ID: 15037686 [Abstract] [Full Text] [Related]
17. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A. Neurology; 1996 Aug 23; 47(2):361-5. PubMed ID: 8757005 [Abstract] [Full Text] [Related]
18. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations. Weidmann E, Unger J, Blair S, Friesen C, Hart C, Cady R. Clin Ther; 2003 Jan 23; 25(1):235-46. PubMed ID: 12637123 [Abstract] [Full Text] [Related]
19. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Ekbom K, Krabbe A, Micieli G, Prusinski A, Cole JA, Pilgrim AJ, Noronha D, Micelli G [corrected to Micieli G]. Cephalalgia; 1995 Jun 23; 15(3):230-6. PubMed ID: 7553814 [Abstract] [Full Text] [Related]
20. Treatment of cluster headache: clinical trials, design and results. Ekbom K. Cephalalgia; 1995 Oct 23; 15 Suppl 15():33-6. PubMed ID: 8749244 [Abstract] [Full Text] [Related] Page: [Next] [New Search]